Manning & Napier Advisors Has Lowered Its Holding in Medtronic Plc (MDT) by $41.10 Million as Market Valuation Rose; Franklin Street Advisors Has Raised Its Stake in Chevron (CVX) by $480,168

November 15, 2017 - By Vivian Park

Franklin Street Advisors Inc increased its stake in Chevron Corporation (CVX) by 6.3% based on its latest 2017Q2 regulatory filing with the SEC. Franklin Street Advisors Inc bought 4,617 shares as the company’s stock declined 3.45% while stock markets rallied. The hedge fund held 77,914 shares of the integrated oil company at the end of 2017Q2, valued at $8.13M, up from 73,297 at the end of the previous reported quarter. Franklin Street Advisors Inc who had been investing in Chevron Corporation for a number of months, seems to be bullish on the $222.07B market cap company. The stock decreased 0.26% or $0.3 during the last trading session, reaching $116.92. About 150 shares traded. Chevron Corporation (NYSE:CVX) has risen 6.68% since November 15, 2016 and is uptrending. It has underperformed by 10.02% the S&P500.

Manning & Napier Advisors Llc decreased its stake in Medtronic Plc (MDT) by 8.24% based on its latest 2017Q2 regulatory filing with the SEC. Manning & Napier Advisors Llc sold 466,989 shares as the company’s stock rose 5.51% with the market. The institutional investor held 5.20 million shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q2, valued at $461.33M, down from 5.67M at the end of the previous reported quarter. Manning & Napier Advisors Llc who had been investing in Medtronic Plc for a number of months, seems to be less bullish one the $107.28B market cap company. The stock decreased 0.03% or $0.02 during the last trading session, reaching $79.16. About shares traded. Medtronic plc. Ordinary Shares (NYSE:MDT) has risen 4.04% since November 15, 2016 and is uptrending. It has underperformed by 12.66% the S&P500.




Investors sentiment decreased to 0.9 in 2017 Q2. Its down 0.06, from 0.96 in 2017Q1. It fall, as 72 investors sold MDT shares while 449 reduced holdings. 99 funds opened positions while 370 raised stakes. 1.06 billion shares or 2.23% less from 1.08 billion shares in 2017Q1 were reported. 4,466 were accumulated by Douglass Winthrop Advsr Ltd Liability. Horrell Cap Management reported 700 shares or 0.04% of all its holdings. Putnam Invs Lc has 24,503 shares. Alpine Woods Investors Llc holds 154,300 shares or 0.73% of its portfolio. Moreover, Letko Brosseau & Incorporated has 0.34% invested in Medtronic plc. Ordinary Shares (NYSE:MDT). Pggm Investments invested in 1.34M shares. Moreover, Fort Washington Investment Advsrs Incorporated Oh has 0.09% invested in Medtronic plc. Ordinary Shares (NYSE:MDT). Thompson Davis Company stated it has 0.11% of its portfolio in Medtronic plc. Ordinary Shares (NYSE:MDT). Columbus Circle Investors reported 28,037 shares. Alliancebernstein LP holds 0.42% or 6.07M shares. Bessemer owns 27,245 shares or 0.01% of their US portfolio. White Pine Capital Limited stated it has 2,836 shares. 4,038 were accumulated by Ssi Inv Mngmt. 11,486 were accumulated by Stevens Capital L P. Quinn Opportunity Ptnrs Lc invested in 0.07% or 5,000 shares.

Among 27 analysts covering Medtronic (NYSE:MDT), 17 have Buy rating, 0 Sell and 10 Hold. Therefore 63% are positive. Medtronic had 70 analyst reports since August 10, 2015 according to SRatingsIntel. The stock of Medtronic plc. Ordinary Shares (NYSE:MDT) earned “Overweight” rating by Morgan Stanley on Wednesday, March 2. The rating was maintained by Needham with “Buy” on Wednesday, August 23. Barclays Capital maintained the shares of MDT in report on Wednesday, August 23 with “Overweight” rating. As per Monday, May 29, the company rating was maintained by IBC. Deutsche Bank maintained Medtronic plc. Ordinary Shares (NYSE:MDT) on Monday, July 31 with “Buy” rating. Bank of America downgraded Medtronic plc. Ordinary Shares (NYSE:MDT) on Tuesday, January 3 to “Neutral” rating. Cowen & Co maintained it with “Buy” rating and $95.0 target in Tuesday, August 22 report. Barclays Capital maintained Medtronic plc. Ordinary Shares (NYSE:MDT) rating on Wednesday, November 23. Barclays Capital has “Overweight” rating and $85 target. The stock of Medtronic plc. Ordinary Shares (NYSE:MDT) earned “Buy” rating by Jefferies on Tuesday, September 26. The stock of Medtronic plc. Ordinary Shares (NYSE:MDT) has “Buy” rating given on Friday, August 26 by Needham.

Analysts await Medtronic plc. Ordinary Shares (NYSE:MDT) to report earnings on November, 21 before the open. They expect $0.96 EPS, down 14.29% or $0.16 from last year’s $1.12 per share. MDT’s profit will be $1.30B for 20.61 P/E if the $0.96 EPS becomes a reality. After $1.12 actual EPS reported by Medtronic plc. Ordinary Shares for the previous quarter, Wall Street now forecasts -14.29% negative EPS growth.

Manning & Napier Advisors Llc, which manages about $52.21B and $11.63 billion US Long portfolio, upped its stake in Home Depot Inc (NYSE:HD) by 14,468 shares to 180,190 shares, valued at $27.64 million in 2017Q2, according to the filing. It also increased its holding in Equity Residential (NYSE:EQR) by 13,965 shares in the quarter, for a total of 117,455 shares, and has risen its stake in Nabors Industries Ltd (NYSE:NBR).

More notable recent Chevron Corporation (NYSE:CVX) news were published by: Seekingalpha.com which released: “Chevron: Q3 Earnings Preview” on October 23, 2017, also Seekingalpha.com with their article: “Chevron: Earnings Preview” published on October 25, 2017, Seekingalpha.com published: “Chevron Corporation – Solid Earnings But Not Enough To Satisfy The Street” on October 31, 2017. More interesting news about Chevron Corporation (NYSE:CVX) were released by: Seekingalpha.com and their article: “Chevron Q3: Good News Despite The Market Reaction” published on November 13, 2017 as well as Seekingalpha.com‘s news article titled: “Chevron: What Are The Risks?” with publication date: November 02, 2017.

Investors sentiment increased to 1.03 in 2017 Q2. Its up 0.06, from 0.97 in 2017Q1. It improved, as 65 investors sold CVX shares while 653 reduced holdings. 92 funds opened positions while 651 raised stakes. 1.16 billion shares or 0.51% more from 1.16 billion shares in 2017Q1 were reported. Buffington Mohr Mcneal accumulated 0.8% or 19,491 shares. Washington-based Sonata Cap Grp has invested 0.66% in Chevron Corporation (NYSE:CVX). Spectrum Asset Mgmt Inc (Nb Ca) holds 20,066 shares. Icon Advisers holds 1.24% or 170,800 shares. Wills Financial Grp Incorporated stated it has 1.61% in Chevron Corporation (NYSE:CVX). Etrade Capital Management Limited Liability Company holds 88,759 shares or 0.36% of its portfolio. Appleton Ma reported 8,007 shares. Moreover, Intl Investors has 2.02% invested in Chevron Corporation (NYSE:CVX). Next Grp Inc holds 0% or 31,392 shares in its portfolio. Balyasny Asset Mgmt Ltd Company invested 0.02% of its portfolio in Chevron Corporation (NYSE:CVX). Vision Mgmt has 3,694 shares for 0.13% of their portfolio. Intersect Ltd holds 33,265 shares or 2.08% of its portfolio. Bryn Mawr Company holds 0.39% in Chevron Corporation (NYSE:CVX) or 62,351 shares. First City Capital Management invested in 12,650 shares. Anchor Advisors Limited Liability holds 0.01% or 2,243 shares in its portfolio.

Franklin Street Advisors Inc, which manages about $2.06 billion and $584.83M US Long portfolio, decreased its stake in Calithera Biosciences Inc. (NASDAQ:CALA) by 40,000 shares to 34,580 shares, valued at $514,000 in 2017Q2, according to the filing. It also reduced its holding in Clorox Company (NYSE:CLX) by 7,464 shares in the quarter, leaving it with 30,815 shares, and cut its stake in Bristolmyers Squibb (NYSE:BMY).

Among 34 analysts covering Chevron Corporation (NYSE:CVX), 23 have Buy rating, 1 Sell and 10 Hold. Therefore 68% are positive. Chevron Corporation had 92 analyst reports since August 4, 2015 according to SRatingsIntel. Piper Jaffray maintained Chevron Corporation (NYSE:CVX) rating on Tuesday, October 10. Piper Jaffray has “Buy” rating and $126.0 target. PiperJaffray upgraded the shares of CVX in report on Tuesday, August 9 to “Overweight” rating. As per Wednesday, March 9, the company rating was maintained by Credit Suisse. CLSA upgraded the stock to “Buy” rating in Tuesday, November 15 report. Bank of America maintained Chevron Corporation (NYSE:CVX) on Tuesday, October 3 with “Buy” rating. The stock of Chevron Corporation (NYSE:CVX) earned “Sector Outperform” rating by Howard Weil on Monday, December 14. Piper Jaffray maintained Chevron Corporation (NYSE:CVX) on Thursday, August 24 with “Buy” rating. Cowen & Co maintained Chevron Corporation (NYSE:CVX) on Tuesday, September 19 with “Buy” rating. The rating was downgraded by Simmons & Co on Thursday, January 21 to “Neutral”. Macquarie Research upgraded the shares of CVX in report on Monday, December 21 to “Outperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.